Trial · NCT01208051
Participant flow45
How many started, completed or left each group, period by period.
1 to 20 of 45
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Total Enrollment | STARTED | Phase I Dose Level 0 | 4 | |
| Total Enrollment | STARTED | Phase I Dose Level +1 | 7 | |
| Total Enrollment | STARTED | Phase I Dose Level +2 | 6 | |
| Total Enrollment | STARTED | Phase II Arm A (Cediranib Maleate) | 39 | |
| Total Enrollment | STARTED | Phase II Arm B (Cediranib Maleate Plus Lenalidomide Thru April 10, 2015) | 71 | |
| Total Enrollment | COMPLETED | Phase I Dose Level 0 | 4 | |
| Total Enrollment | COMPLETED | Phase I Dose Level +1 | 6 | |
| Total Enrollment | COMPLETED | Phase I Dose Level +2 | 5 | |
| Total Enrollment | COMPLETED | Phase II Arm A (Cediranib Maleate) | 39 | |
| Total Enrollment | COMPLETED | Phase II Arm B (Cediranib Maleate Plus Lenalidomide Thru April 10, 2015) | 69 | |
| Total Enrollment | NOT COMPLETED | Phase I Dose Level 0 | 0 | |
| Total Enrollment | NOT COMPLETED | Phase I Dose Level +1 | 1 | |
| Total Enrollment | NOT COMPLETED | Phase I Dose Level +2 | 1 | |
| Total Enrollment | NOT COMPLETED | Phase II Arm A (Cediranib Maleate) | 0 | |
| Total Enrollment | NOT COMPLETED | Phase II Arm B (Cediranib Maleate Plus Lenalidomide Thru April 10, 2015) | 2 | |
| Interim Futility Analysis | STARTED | Phase I Dose Level 0 | 0 | |
| Interim Futility Analysis | STARTED | Phase I Dose Level +1 | 0 | |
| Interim Futility Analysis | STARTED | Phase I Dose Level +2 | 0 | |
| Interim Futility Analysis | STARTED | Phase II Arm A (Cediranib Maleate) | 39 | |
| Interim Futility Analysis | STARTED | Phase II Arm B (Cediranib Maleate Plus Lenalidomide Thru April 10, 2015) | 68 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01208051/flow